Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

By M. Yoder, L. Mead, D. Prater, Theresa R. Krier, Karim N Mroueh, Fang Li, Rachel Krasich, C. Temm, J. Prchal, D. Ingram. Blood, 2007

1,532 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/49f8fdcc2a959974c81a2c08d4f40ef2131a8a41

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Peter Libby
2. Christian Weber
3. A. Zernecke
4. G. Hansson
5. P. Ridker

In Molecular Biology

1. Peter Libby
2. Christian Weber
3. A. Zernecke

Citations in the corpus

• The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (2008, background): “Recent refinements have indeed revealed that late endothelial outgrowth cells that have vessel-forming capacity (or endothelial-colony-forming cells) are not derived from CD133 + or CD34 + CD45 + haematopoietic precursor cells, which can generate early EPC-like monocytes, but from CD34 + CD45 − c”
• The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. (2007, background): “EPCs are characterized by stem cell markers, ie, CD133 and CD34, a high proliferative capacity, and the ability to form blood vessels.(22) DCs are identified by S100, an intracellular calciumbinding protein.”